Hello, Guest!
  • Thursday, November 21, 2024

Moderna Secures $3.3B Army Contract Modification to Supply Additional 200M COVID-19 Vaccine Doses

Moderna (Nasdaq: MRNA) has secured a $3.3 billion contract modification from the U.S. Army for additional 200 million filled drug production doses of its SARS-CoV-2 mRNA-1273 vaccine, bringing the total confirmed government order to 500 million doses.

The Department of Defense said Monday the biotechnology company will conduct production work at its Cambridge, Massachusetts facility and complete deliveries by approximately the end of March 2022.

In a Wednesday press release, Moderna noted it aims to hand over 110 million vaccine doses to the government in the fourth quarter of the current calendar year and the remaining 90 million doses in the first quarter of 2022.

The award also includes an option for the government to buy other Moderna COVID-19 vaccine candidates.

Army Contracting Command obligated the full contract modification amount from the service branch’s research, development, test and evaluation funds at the time of the award.

To date, Moderna has supplied 217 million COVID-19 vaccine doses to the U.S. government.

Video of the Day

Related Articles

Moderna to Supply New COVID-19 Vaccine Booster Under $1.74B Contract With US Government Contract Awards

Moderna to Supply New COVID-19 Vaccine Booster Under $1.74B Contract With US Government

Moderna (Nasdaq: MRNA) has received a potential $1.74 billion contract to initially produce and deliver 66 million doses of its COVID-19 vaccine booster candidate to the U.S. government. The contract calls for the delivery of the initial doses in 2022 and includes options for the government to buy 234 million more doses of Moderna’s mRNA-1273.222

HHS, DOD Sign $3.65B in COVID-19 Vaccine Deals With Pfizer-BioNTech, Moderna News

HHS, DOD Sign $3.65B in COVID-19 Vaccine Deals With Pfizer-BioNTech, Moderna

The departments of Health and Human Services and Defense have earmarked $3.65 billion to buy 100 million additional doses of COVID-19 vaccines each from Pfizer (NYSE: PFE) and Moderna (Nasdaq: MRNA), bringing the total number of vaccines bought from the companies to 600 million doses. The U.S. government agreed to pay $2 billion to Pfizer and its Germany-based partner BioNTech and $1.65 billion to Moderna for the additional doses.

Moderna to Produce Additional COVID-19 Vaccines Under $2B Army Contract Modification Contract Awards

Moderna to Produce Additional COVID-19 Vaccines Under $2B Army Contract Modification

Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's messenger RNA vaccine against the novel coronavirus.